FDA — authorised 2 May 1989
- Status: approved
🇺🇸 Lariam in United States
FDA authorised Lariam on 2 May 1989
Marketing authorisations
FDA — authorised 2 May 1989
- Application: NDA019591
- Marketing authorisation holder: ROCHE
- Local brand name: LARIAM
- Indication: TABLET — ORAL
- Status: approved
Lariam in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Lariam approved in United States?
Yes. FDA authorised it on 2 May 1989; FDA authorised it on 2 May 1989.
Who is the marketing authorisation holder for Lariam in United States?
Marketing authorisation holder not available in our data.